First description of revertant mosaicism in familial platelet disorder with predisposition to acute myelogenous leukemia: Correlation with the clinical phenotype

Ana C. Glembotsky; Cecilia P. Marin Oyarzún; Geraldine de Luca; Christophe Marzac; Nathalie Auger; Nora P. Goette; Rosana F. Marta; Hana Raslova; Paula G. Heller

doi:10.3324/haematol.2020.253070

First description of revertant mosaicism in familial platelet disorder with predisposition to acute myelogenous leukemia: Correlation with the clinical phenotype

Ana C. Glembotsky, Cecilia P. Marin Oyarzún, Geraldine de Luca, Christophe Marzac, Nathalie Auger, Nora P. Goette, Rosana F. Marta, Hana Raslova, Paula G. Heller

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	535-539
Number of pages	5
Journal	Haematologica
Volume	105
Issue number	10
DOIs	https://doi.org/10.3324/haematol.2020.253070
Publication status	Published - 1 Oct 2020

Access to Document

10.3324/haematol.2020.253070

Cite this

Glembotsky, A. C., Marin Oyarzún, C. P., de Luca, G., Marzac, C., Auger, N., Goette, N. P., Marta, R. F., Raslova, H., & Heller, P. G. (2020). First description of revertant mosaicism in familial platelet disorder with predisposition to acute myelogenous leukemia: Correlation with the clinical phenotype. Haematologica, 105(10), 535-539. https://doi.org/10.3324/haematol.2020.253070

@article{b18959a038694ad1af70266f0c3ed5c5,

title = "First description of revertant mosaicism in familial platelet disorder with predisposition to acute myelogenous leukemia: Correlation with the clinical phenotype",

author = "Glembotsky, {Ana C.} and {Marin Oyarz{\'u}n}, {Cecilia P.} and {de Luca}, Geraldine and Christophe Marzac and Nathalie Auger and Goette, {Nora P.} and Marta, {Rosana F.} and Hana Raslova and Heller, {Paula G.}",

note = "Funding Information: Funding: this study was supported by grants from the Fondation Nelia et Amadeo Barletta (to PH, 2017), the Ligue Nationale Contre le Cancer ({\'e}quipe labellis{\'e}e 2019 to HR) and the cooperation program between France and Argentina, Ecos-Sud-Ministerio de Ciencia, Tecnolog{\'i}a e Innovaci{\'o}n Productiva (MINCyT) (to HR and PH, 2016). CMO was supported by a postdoctoral fellowship from the Fondation Nelia et Amadeo Barletta and from the Fondation de la Recherche M{\'e}dicale. Correspondence: PAULA G. HELLER - [email protected] doi:10.3324/haematol.2020.253070",

year = "2020",

month = oct,

day = "1",

doi = "10.3324/haematol.2020.253070",

language = "English",

volume = "105",

pages = "535--539",

journal = "Haematologica",

issn = "0390-6078",

number = "10",

}

Glembotsky, AC, Marin Oyarzún, CP, de Luca, G, Marzac, C, Auger, N, Goette, NP, Marta, RF, Raslova, H & Heller, PG 2020, 'First description of revertant mosaicism in familial platelet disorder with predisposition to acute myelogenous leukemia: Correlation with the clinical phenotype', Haematologica, vol. 105, no. 10, pp. 535-539. https://doi.org/10.3324/haematol.2020.253070

TY - JOUR

T1 - First description of revertant mosaicism in familial platelet disorder with predisposition to acute myelogenous leukemia

T2 - Correlation with the clinical phenotype

AU - Glembotsky, Ana C.

AU - Marin Oyarzún, Cecilia P.

AU - de Luca, Geraldine

AU - Marzac, Christophe

AU - Auger, Nathalie

AU - Goette, Nora P.

AU - Marta, Rosana F.

AU - Raslova, Hana

AU - Heller, Paula G.

N1 - Funding Information: Funding: this study was supported by grants from the Fondation Nelia et Amadeo Barletta (to PH, 2017), the Ligue Nationale Contre le Cancer (équipe labellisée 2019 to HR) and the cooperation program between France and Argentina, Ecos-Sud-Ministerio de Ciencia, Tecnología e Innovación Productiva (MINCyT) (to HR and PH, 2016). CMO was supported by a postdoctoral fellowship from the Fondation Nelia et Amadeo Barletta and from the Fondation de la Recherche Médicale. Correspondence: PAULA G. HELLER - [email protected] doi:10.3324/haematol.2020.253070

PY - 2020/10/1

Y1 - 2020/10/1

UR - http://www.scopus.com/inward/record.url?scp=85092303420&partnerID=8YFLogxK

U2 - 10.3324/haematol.2020.253070

DO - 10.3324/haematol.2020.253070

M3 - Article

C2 - 33054100

AN - SCOPUS:85092303420

SN - 0390-6078

VL - 105

SP - 535

EP - 539

JO - Haematologica

JF - Haematologica

IS - 10

ER -

First description of revertant mosaicism in familial platelet disorder with predisposition to acute myelogenous leukemia: Correlation with the clinical phenotype

Access to Document

Other files and links

Cite this